NCT06177093View on ClinicalTrials.gov

De-escalated Dose SBRT in Localized Prostate Cancer (DESTINATION-MRL)

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 11, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2027

Conditions
Prostate Cancer
Interventions
RADIATION

MR Linac delivered Radiotherapy

All radiotherapy will be delivered on the MR-linac. The whole prostate will receive 30 Gy in 5 fractions and the dominant lesion plus intra-prostatic margin will receive an isotoxic 45 Gy prescription.

Trial Locations (1)

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER